BASAGLAR KwikPen insulin glargine (rbe) 100 IU/mL solution for injection cartridge

Riik: Austraalia

keel: inglise

Allikas: Department of Health (Therapeutic Goods Administration)

Osta kohe

Avaliku hindamisaruande Avaliku hindamisaruande (PAR)
26-11-2017

Toimeaine:

Insulin glargine, Quantity: 100 IU/mg

Saadav alates:

Eli Lilly Australia Pty Ltd

INN (Rahvusvaheline Nimetus):

Insulin glargine

Ravimvorm:

Injection, solution

Koostis:

Excipient Ingredients: dilute hydrochloric acid; glycerol; sodium hydroxide; water for injections; metacresol; zinc oxide

Manustamisviis:

Subcutaneous

Ühikuid pakis:

2, 5, 10, 1

Retsepti tüüp:

(S4) Prescription Only Medicine

Näidustused:

Insulin glargine is an insulin analogue indicated for once-daily subcutaneous administration in the treatment of type 1 diabetes mellitus in adults and children and type 2 diabetes mellitus in adults who require insulin for the control of hypeglycaemia.

Toote kokkuvõte:

Visual Identification: Clear to colourless solution; Container Type: Cartridge; Container Material: Glass Type I Clear; Container Life Time: 2 Years; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Volitamisolek:

Licence status A

Loa andmise kuupäev:

2014-11-21